Recently, the National Medical Products Administration (NMPA) conducted regular inspections on Medicilon Biopharmaceutical’s implementation of the “GLP”. The inspection results showed that Medicilon is in the organization and management of drug safety evaluation. And results, whether the personnel, equipment and experimental materials, standard operating procedures and test operation meet the GLP requirements. The inspection resultsRead more